Search results
- any standard method or process in clinical research4 statements, 0 sitelinks - 23:39, 3 June 2023
- phase of clinical research in medicine15 statements, 0 sitelinks - 23:37, 3 June 2023
- preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications3 statements, 0 sitelinks - 22:06, 3 June 2023
- healthcare profession5 statements, 0 sitelinks - 23:03, 3 June 2023
- oversight and administrative efforts that monitor a participant's health and efficacy of the treatment during a clinical trial4 statements, 0 sitelinks - 23:04, 3 June 2023
- <!-- Clinical data --> ==Clinical trials== ...7 KB (1,058 words) - 21:01, 20 February 2024
- ...The most advanced of these drugs is [[mazdutide]] which is in a phase III trial as of 2023. ...onist would provide additive or synergistic metabolic benefits. A clinical trial of the triple agonist [[retatrutide]] found an average −24.2 percent weight ...3 KB (451 words) - 22:02, 2 April 2024
- <!-- Clinical data --> ==Clinical trials== <!--T:8--> ...7 KB (1,098 words) - 21:00, 20 February 2024
- ...The most advanced of these drugs is [[mazdutide]] which is in a phase III trial as of 2023. ...onist would provide additive or synergistic metabolic benefits. A clinical trial of the triple agonist [[retatrutide]] found an average −24.2 percent weight ...3 KB (471 words) - 22:01, 2 April 2024
- ...nidine]]. Because of these results, pyridoxamine has been investigated for clinical utility in the treatment of [[diabetic nephropathy]]. ...eady made (about $100M) much less on the additional investment a Phase III trial would require. To solve this problem, Biostratum submitted a [[citizen peti ...9 KB (1,212 words) - 14:40, 4 April 2024
- ...nidine]]. Because of these results, pyridoxamine has been investigated for clinical utility in the treatment of [[diabetic nephropathy]]. ...eady made (about $100M) much less on the additional investment a Phase III trial would require. To solve this problem, Biostratum submitted a [[citizen peti ...9 KB (1,244 words) - 14:38, 4 April 2024
- ...ound that it improved aerobic capacity in amateur runners. A 2023 clinical trial showed that NMN improves performance on a six-minute walking test and a sub .... The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023 Nov;14(6):1416-1435. doi: 10.1016/j.advnu ...6 KB (755 words) - 08:49, 8 April 2024
- ...ound that it improved aerobic capacity in amateur runners. A 2023 clinical trial showed that NMN improves performance on a six-minute walking test and a sub .... The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023 Nov;14(6):1416-1435. doi: 10.1016/j.advnu ...6 KB (779 words) - 08:48, 8 April 2024
- <!-- Clinical data --> ...eople who cannot tolerate allopurinol. [[National Institute for Health and Clinical Excellence]] concluded that febuxostat is more effective than standard dose ...9 KB (1,260 words) - 20:24, 22 April 2024
- <!-- Clinical data --> ...eople who cannot tolerate allopurinol. [[National Institute for Health and Clinical Excellence]] concluded that febuxostat is more effective than standard dose ...9 KB (1,308 words) - 20:19, 22 April 2024
- <!--Clinical data--> Adverse effects found in clinical trials are usually limited to headache and gastrointestinal discomfort when ...5 KB (702 words) - 11:03, 3 April 2024
- <!--Clinical data--> Adverse effects found in clinical trials are usually limited to headache and gastrointestinal discomfort when ...5 KB (738 words) - 11:00, 3 April 2024
- ...a COVID-19ワクチン]]である。2022年現在、同社は44の治療薬およびワクチン候補を有しており、そのうち21が[[:en:clinical trial|臨床試験]]に移行している。ワクチン候補のターゲットには、[[:en:influenza|インフルエンザ]]、[[:en:HIV|HIV]]、[[:e ...DA)は[[:en:Moderna COVID-19 vaccine|Moderna COVID-19ワクチン]]候補の[[:en:clinical trial|臨床試験]]を承認し、Modernaは[[Wikipedia:Operation Warp Speed|Operation Warp Speed]]か ...16 KB (841 words) - 11:23, 2 January 2024
- ...s – from concept through preclinical testing in the laboratory to clinical trial development, including Phase I–III trials – to approved vaccine or drug typ Broadly, the process of drug development can be divided into preclinical and clinical work. ...26 KB (3,425 words) - 08:08, 4 January 2023
- <!-- Clinical data --> The medication's phase 3 clinical trial program demonstrated reductions in hemoglobin A1c of approximately 1% with ...9 KB (1,155 words) - 10:30, 12 February 2024